Saliva Levels of S100A12, CRP, Fetuin-A in Periodontal Disease Patients
Launched by T.C. ORDU ÜNİVERSİTESİ · Nov 16, 2017
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • never-smokers no history of systemic disease no patients had been under periodontal therapy and medicine for at least 6 months before the study no pregnancy or lactation no alcohol or antioxidant vitamin consumption.
- Exclusion Criteria:
- • -
About T.C. Ordu üni̇versi̇tesi̇
T.C. Ordu Üniversitesi is a prominent academic institution in Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to conduct innovative research aimed at improving healthcare outcomes. With a focus on ethical practices and regulatory compliance, T.C. Ordu Üniversitesi fosters collaboration among multidisciplinary teams to explore new therapeutic approaches and contribute to the scientific community. The institution is committed to enhancing patient care through rigorous clinical trials that align with its mission of promoting health and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ordu, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials